Summary: Over a period of three years we determined haptoglobin levels by single radial immunodiffusion (RID) and the haptoglobin phenotype in over 1700 samples of patients suspected of a haemolytic disease.
Introduction
A number of analytical methods are available to the clinician when searching for the cause of a haemolytic disease. In cases of haemolysis, determination of the decreased red blood cell survival and of the number of reticulocytes can be helpful in the diagnosis.
However, in comparatively mild forms of a haemolytic process, the reticulocyte count lacks conclusiveness and any diagnosis derived from it is doubtful (DRecently, Marchand et al. (2) supported the routine use of the serum haptoglobin determination in the diagnosis of haemolytic diseases.
There exists, however, a large biological inter-individual Variation in normals, so that the clinical usefulness of a single haptoglobin value has been questioned (3).
Moreover, one has to take into account the fact that haemolytic diseases are often accompanied by inflammatory processes which tend to offset the lowering of the haptoglobin level that goes with the haemolytic condition.
Besides other parameters, haptoglobin is determined routinely in our clinic to Support the diagnosis of haemolytic disease; for this purpose single radial immunodiffusion is used (4). However, in using this technique a calculation of the exact level of haptoglobin requires the determination of the haptoglobin phenotype, which is time-consuming and expensive.
We therefore raised the question of whether and when the phenotype determination can be omitted for clinical purposes. We considered only low haptoglobin levels, which are indicative of intravascular haemolysis of a deficient liver haptoglobin synthesis. Haptoglobin levels above normal, which can be indicative of an inflammatory process, were not taken into consideration.
We evaluated the serum haptoglobin levels determined over a period of three years in a wide variety of patients with suspected haemolytic disease. All levels without and with typing were considered, attention being focussed on levels which changed from normal to lowered and the number of levels which changed from lowered to normal äs a result of phenotyping.
Materials and Methods
Reagents, equipment and methods were äs described previously (5). Mancin?s method (4) was used for the RID technique. Typing of haptoglobin was done by polyacrylamide gel electrophoresis (5) . Serum samples were all from patients with suspected haemolysis. The main findings in the peripheral blood were anaemia and/or reticulocytosis, sometimes accompanied by elevated serum bilirubin levels and/or increased serum lactate dehydrogenase levels.
Results arod Discussion
During a three year period, 1744 patient samples were received in our laboratory, 86.3% from men and 13.7% from women. This rather unusual distribution arises because the patients in our hospital are basically army personnel. According to the gel electrophoresis pattern six patients showed the Johnson type of haptoglobin, while the serum haptoglobin level in 106 patients was too low (below 200 mg/1) to determine the haptoglobin phenotype. For the femaining 1632 samples the total haptoglobin level (untyped) and the phenotype (1-1, 2-1 or 2-2) were determined. For the untyped haptoglobin level the over-all reference ränge of 500-3300 mg/1 was used, while for the phenotypes 1-1, 2-1, and 2-2 the reference ranges were 700-2300, 900-3600 and 600-2900 mg/1 serum, respectively (5). The factors taking into account the three phenotypes were 0.6, 1.3, and 1.5 respectively, in accordance with the Information of the manufactürer of the RID plates. * *Ã s already mentioned the aim of this retrospective study was to answer the question of whether it is al·· ways necessary to perform a haptoglobin phenotyping. Oii theoretical grounds one can decide to perform phenotyping when total haptoglobin is in the ränge 400-1170 mg/1. This idea is based on the reference ranges for the three genetic types and their respective conversion factors and can be exemplified äs follows.
A patient sample with a value* Hp =1160 mg/1 and belonging to type Hp 1-1 becomes 690 ing/i when the genetic type is taken into account. The reference ränge for this type is 700-2300 mg/1. Hence, values below 1170 mg/1 are "lowered" when the genetic type is Hp 1-1 and the appropriate factor is äpplied. It is therefore valid to question the necessity of typing all the serurn samples with values lower than 1170 mg/1. This question can be answered by considering the reference ranges of the genetic types (5, 6) and their factors. A serum sample with a Hp value below 400 mg/1 is "lowered" whatever the genetic type. Higher values come within the reference ränge if the genetic type happens to be Hp 2-2, because the conversion factor for this type is 1.5.
As already mentioned, if the level is above normal, indicating for instance an acute inflammatory ptocess, phenotyping can also be ignored. This is because we are interested only in whether this determination supports the diagnosis of a haemolytic disease.
It appeared that in our total sample group (1632 samples) a large number (480 samples) had values between 400 and 1170 mg/1. So if one decides to ignore Hp phenotyping, and to perform this determination only when the values of the total haptoglobin determination lie in the ränge 400 to 1170 rng/1, one can considerably reduce the work load and the costs of this test.
In this context the question arises äs to the distribution of the observed haptoglobin values both without and with phenotyping. As can be seen from table l, Tab 10 samples (3.9% out of 255) in the type 1-1 category and 26 samples (3.4% out of 757) in the type 2-1 category were classified äs normal according to the untyped reference ränge, but lowered when referring to their phenotype ränge. In the case of type 2-2, 36 samples (5.8% out of 620) were lowered according to the over-all reference ränge, but normal according to the phenotype reference ränge. The other discrepancies are between "normal" and "above normal" and are thus not of relevance here.
In total this means that determination of phenotype alters the diagnosis in only 72 samples (10 of type 1-1, 26 of type 2-2 and 36 of type 2-2), which represents only 4% of the total 1632 samples and 15% of the samples in the ränge between 400 and 1170 mg/1. In all other patient samples the influence of the genetic type is minor, i.e. the sample values are above or below the lower limit of the reference ränge, whether phenotyped or not.
Another question that now arises is: within these 72 cases, how many patients with established haemolytic diseases would be diagnosed differently without and with phenotyping? Only with these data one can decide whether or not the phenotypic determinations must be performed routinely in large groups of persons with suspected haemolytic disease. Careful examination of the medical records revealed that in a number of patients the haptoglobin determination was performed more than once, so that the 72 determinations under consideration were actually performed on 63 patients. It also appeared from the medical records that only three had an established severe haemolytic disease. The diagnoses were based on a number of clinical features of haemolysis such äs jaundice, hepatosplenomegaly and the laboratory approach to the investigation of the anaemia. The other determinations were performed for patients with various diseases including M. Patients with a haemolysis were present in all three categories of phenotypes. So without withdrawing important clinical Information it appeared necessary to perform phenotyping only for those patients with untyped haptoglobin values lying between 400 and 1170 mg/1; these limits are calculated from the reference ranges and RIO factors of the three phenotypes.
With regard to the above results, the clinical chemist can make a contribution to reducing escälating medical costs by decreasing the excessive use of diagnostic tests and procedures. In addition to efforts directed at changing physician's behaviour in asking for unnecessary or inappropiate tests, the clinical chemist should also produce data that carry maximal information. So we decided in our clinic to perform phenotyping only when the untyped values are in the rather narrow ränge of 400 to 1170 mg/1. In this way we reduce the workload of phenotyping by about 70%, without loss of any important clinical Information.
Beyond the scope of this study is the question äs to whether this test is ideal for both ruling out and confirming haemolysis. Such an attempt has been made for the haptoglobin determination (2), though some objections against this study have been reported (7) . However, with regard to the literattire and the results of our study we believe that it is permissible to try to persuade the clinician to abolish phenotyping and therefore accept a less quantitative result beyond the earlier mentioned ränge; we believe that enough useful clinical Information is given by a result obtained in this way.
